E-LIB Suche - Ergebnisse für: Schoser, Benedikt

1

Therapeutic resistance training: proposal for an algorithm-..:

Weber, Frank ; Stark, Christina ; Bloch, Wilhelm...
Translational Exercise Biomedicine. 1 (2024) 1 - p. 89-101 , 2024

2

COMET post hoc analysis: Efficacy of long-term avalglucosid..:

Toscano, Antonio ; Kishnani, Priya ; Dimachkie, Mazen M....
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 108058 , 2024

Link: https://doi.org/10.1016/..

3

Meta-analysis towards FSHD reveals misregulation of neuromu..:

Schätzl, Teresa ; Todorow, Vanessa ; Kaiser, Lars...
Communications Biology. 7 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Minimal clinically important differences in six-minute walk..:

Schoser, Benedikt ; Kushlaf, Hani ; Hummel, Noemi...
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 108032 , 2024

Link: https://doi.org/10.1016/..

5

Acid α-glucosidase (GAA) activity and glycogen content in m..:

Schoser, Benedikt ; Raben, Nina ; Varfaj, Fatbardha..
Molecular Genetics and Metabolism Reports. 39 (2024) - p. 101085 , 2024

Link: https://doi.org/10.1016/..

6

Switching treatment to cipaglucosidase alfa plus miglustat ..:

Toscano, Antonio ; Byrne, Barry J. ; Claeys, Kristl G....
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 108059 , 2024

Link: https://doi.org/10.1016/..

7

Effect size analysis of cipaglucosidase alfa plus miglustat..:

Mozaffar, Tahseen ; Bratkovic, Drago ; Byrne, Barry J....
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 107971 , 2024

Link: https://doi.org/10.1016/..

8

Efficacy and safety of iscalimab, a novel anti-CD40 monoclo..:

GomezMancilla, Baltazar ; Meriggioli, Matthew N. ; Genge, Angela...
Journal of Clinical Neuroscience. 119 (2024) - p. 76-84 , 2024

Link: https://doi.org/10.1016/..

9

Anti-Ku + myositis: an acquired inflammatory protein-aggreg..:

Holzer, Marie-Therese ; Uruha, Akinori ; Roos, Andreas...
Acta Neuropathologica. 148 (2024) 1 - p. , 2024

Link: https://doi.org/10.1007/..

10

P028: Switching treatment to cipaglucosidase alfa+miglustat..:

Kishnani, Priya ; Byrne, Barry ; Claeys, Kristl...
Genetics in Medicine Open. 2 (2024) - p. 100905 , 2024

Link: https://doi.org/10.1016/..

11

104-week efficacy and safety of cipaglucosidase alfa plus m..:

Schoser, Benedikt ; Kishnani, Priya S. ; Bratkovic, Drago...
Journal of Neurology. 271 (2024) 5 - p. 2810-2823 , 2024

Link: https://doi.org/10.1007/..

12

Effect of avalglucosidase alfa on disease-specific and gene..:

Toscano, Antonio ; Pollissard, Laurence ; Msihid, Jérôme...
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 108121 , 2024

Link: https://doi.org/10.1016/..

13

Variability of GAA enzyme and glycogen levels in different ..:

Schoser, Benedikt ; Meinke, Peter ; Graupner, Alexandra..
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 108031 , 2024

Link: https://doi.org/10.1016/..

14

Start, switch and stop (triple‐S) criteria for enzyme repla..:

Schoser, Benedikt ; van der Beek, Nadine A. M. E. ; Broomfield, Alexander...
European Journal of Neurology. 31 (2024) 9 - p. , 2024

Link: https://doi.org/10.1111/..

15

NEO1/NEO-EXT studies: Long-term muscle quantitative magneti..:

Byrne, Barry ; Carlier, Pierre G. ; Vissing, John...
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 107783 , 2024

Link: https://doi.org/10.1016/..